Related Experiment Video
Updated: Jan 20, 2026

Evaluating Cell Death Signaling by Immunofluorescence in a Rat Model of Ischemic Stroke
Published on: January 3, 2025
Impact of Cholesterol on Ischemic Stroke in Different Human-Like Hamster Models: A New Animal Model for Ischemic
Lili Wei1,2, Haozhe Shi1, Xiao Lin1
1Key Laboratory of Molecular Cardiovascular Sciences, Institute of Cardiovascular Sciences, Ministry of Education, Peking University, Beijing 100191, China.
Insights
Familial hypercholesterolemia (high LDL-C) and Tangier's disease (low HDL-C) are risk factors for ischemic stroke (IS). A new method, c-MCAO, effectively models IS in genetically engineered hamsters.
Area of Science:
- Neuroscience
- Cardiovascular Science
- Genetics
Background:
- High low-density lipoprotein cholesterol (LDL-C) and low high-density lipoprotein cholesterol (HDL-C) are linked to cardiovascular events.
- The specific impact of familial hypercholesterolemia (FH) and Tangier's disease (TD) on ischemic stroke (IS) risk in humans remains unclear.
- FH is caused by LDLR mutations, while TD results from ABCA1 mutations.
Purpose of the Study:
- To develop a more efficient method for inducing IS.
- To investigate the precise effects of different lipoprotein levels on IS.
- To assess the role of FH and TD in IS pathogenesis using a novel animal model.
Main Methods:
- A novel contralateral middle cerebral artery occlusion (c-MCAO) technique was employed in human-like hamster models to induce IS.
- The c-MCAO method was compared to traditional distal MCAO (d-MCAO).
- Homozygous and heterozygous LDLR knockout (LDLR-/- and LDLR+/-) and ABCA1 knockout (ABCA1-/-) hamsters were utilized, alongside wild-type (WT) controls.
Main Results:
- The c-MCAO technique induced more severe IS with larger infarct sizes and greater blood-brain barrier (BBB) disruption compared to d-MCAO.
- Both homozygous LDLR deficiency (high LDL-C) and ABCA1 deficiency (severe low HDL-C) significantly increased brain infarct volume and BBB leakage in hamsters.
- Heterozygous LDLR knockout hamsters did not show a significant increase in IS severity compared to WT controls.
Conclusions:
- High LDL-C levels (due to LDLR deficiency) and severely low HDL-C levels (due to ABCA1 deficiency) are identified as risk factors for IS.
- The developed c-MCAO hamster model is suitable for future studies on ischemic stroke and reperfusion.
- This study provides valuable insights into the genetic and lipid-related underpinnings of ischemic stroke.
Rationale:
While high low-density lipoprotein cholesterol (LDL-C) and low high-density lipoprotein cholesterol (HDL-C) levels are positively associated with cardiovascular events, it is still unclear whether familial hypercholesterolemia (FH) and Tangier's disease (TD), caused by mutations in LDLR and ABCA1, respectively, influence ischemic stroke (IS) in humans.
Objective:
We sought to establish an easier, more effective, and time-saving method to induce IS, then studied the precise effects of different types of lipoproteins on IS.
Methods And Results:
A new technique termed contralateral middle cerebral artery occlusion (c-MCAO) was introduced to human-like hamster models to induce IS. Compared to traditional distal MCAO (d-MCAO) induced by electrocoagulation, c-MCAO resulted in a more severe IS with larger infarct sizes and more blood-brain barrier (BBB) disruption after 24 h. It was shown that c-MCAO markedly elicited an increase in brain infarct volume and BBB leakage in both homozygous LDLR (LDLR-/-) and ABCA1 knockout (ABCA1-/-) hamsters, but not in heterozygous LDLR knockout (LDLR+/-) hamsters when compared to wild-type (WT) controls.
Conclusions:
Using human-like genetically engineered hamsters, our findings demonstrated that both high LDL-C level caused by homozygous LDLR deficiency and severe low HDL-C level caused by deleting ABCA1 were risk factors of IS. As such, we believe the development of this novel IS hamster model is suitable for future ischemic/reperfusion studies.
Related Concept Videos
Assessing the Angiogenesis Effects of a Test Drug in a Rat Model of Ischemic Stroke
11:32Evaluating Cell Death Signaling by Immunofluorescence in a Rat Model of Ischemic Stroke
09:00Real-Time Monitoring and Modulation of Blood Pressure in a Rabbit Model of Ischemic Stroke
11:06A Triple Primary Cell Culture Model of the Human Blood-Brain Barrier for Studying Ischemic Stroke In Vitro
12:01PET Imaging of Neuroinflammation Using [11C]DPA-713 in a Mouse Model of Ischemic Stroke
12:19An In Vivo Assessment of Blood-Brain Barrier Disruption in a Rat Model of Ischemic Stroke
